Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
NK Cell Subsets in Health and Disease: New Developments
| NK Cell Subsets in Health and Disease: New Developments |
| Autore | Emanuela Marcenaro |
| Pubbl/distr/stampa | Frontiers Media SA, 2017 |
| Descrizione fisica | 1 electronic resource (243 p.) |
| Collana | Frontiers Research Topics |
| Soggetto non controllato |
ILCs
inflammation NK cell subsets immunotherapy anti-viral responses anti-tumor responses immune checkpoints |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | NK Cell Subsets in Health and Disease |
| Record Nr. | UNINA-9910261136003321 |
Emanuela Marcenaro
|
||
| Frontiers Media SA, 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
NKT Cells in Cancer Immunotherapy
| NKT Cells in Cancer Immunotherapy |
| Autore | Webb Tonya J |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 electronic resource (178 p.) |
| Soggetto topico |
Medicine
Immunology |
| Soggetto non controllato |
iNKT
CD1d dendritic cells α-GalCer cancer immunotherapy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557784703321 |
|
Webb Tonya J
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
NKT Cells in Cancer Immunotherapy, 2nd Edition
| NKT Cells in Cancer Immunotherapy, 2nd Edition |
| Autore | Webb Tonya J |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 electronic resource (178 p.) |
| Soggetto topico |
Medicine
Immunology |
| Soggetto non controllato |
iNKT
CD1d dendritic cells α-GalCer cancer immunotherapy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557644703321 |
|
Webb Tonya J
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
| Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments |
| Autore | Uchino Junji |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (258 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
non-small cell lung cancer
previously treated patients phase I/II trial chemotherapy docetaxel S-1 immunotherapy rechallenge retrospective analysis pulmonary pleomorphic carcinoma prognostic factor glucose transporter 1 lung cancer multiple cancers metastasis sequencing mutation genomic diagnosis FDG-PET immune checkpoint inhibitor PD-1 prognosis RAD51B methylation PD-L1 expression predictive biomarker PD-1 blockade interstitial lung disease pulmonary fibrosis radiology and other imaging non-small-cell lung cancer epidermal growth factor receptor tyrosine kinase inhibitors TP53 mutations responsiveness targeted therapy network meta-analysis stage IIIA-N2 surgery immune checkpoint inhibitors biomarker nonsmall cell lung cancer HIP1R PD-L1 RUNX1 methylation survival EGFR-TKI T790M osimertinib immune-related adverse events endocrine disorders tumor-bearing patients PD-1 inhibitors PD-L1 inhibitors meta-analysis nivolumab Expanded Access Program real-world data daily practice prognostic factors NSCLC KRAS DNA polymerase beta platinum-based first-line adjuvant chemotherapy β-catenin lung neoplasms nucleotide-diphosphate kinase recurrence unresectable salvage surgery oligometastasis |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Non-small Cell Lung Cancer |
| Record Nr. | UNINA-9910557489703321 |
|
Uchino Junji
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Treatment Strategies for Glioblastoma
| Novel Treatment Strategies for Glioblastoma |
| Autore | Stylli Stanley |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (268 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
glioblastoma
glioma temozolomide radiotherapy immunotherapy novel therapy personalized treatment drug repurposing invasion invadopodia ion channels gene therapy viral vectors brain tumor nanomedicine cancer stem cell targeted therapy brain cancer cell cycle differentiation proliferation RAS SRGAP2 stem cell TP53 glioblastoma multiforme GBM nerve/glial antigen 2 NG2 CK2 CX-4945 migration CRISPR/Cas9 anticancer anti-angiogenesis thyrointegrin αvβ3 PEG triazole tetrac P-bi-TAT P-m-TAT tetrac one-carbon metabolism de novo purine synthesis metabolic reprogramming metabolic treatment vaccine immune checkpoint inhibitors chimeric antigen receptor (CAR) T cells glioblastoma (GB) prolyl-oligopeptidase (POP) vascular endothelial growth factor (VEGF) transforming growth factor-β (TGF-β) angiopoietin (Ang) endothelial nitric oxide synthase (eNOS) newly diagnosed glioblastoma recurrent glioblastoma new trial design drug-inducible gene expression Mardepodect Regorafenib drug targets tumor antigens renin-angiotensin system pluripotent stem cells organoids cancer stem cells cancer stem cell niche tumor microenvironment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557363703321 |
|
Stylli Stanley
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Oncolytic Virus Immunotherapy
| Oncolytic Virus Immunotherapy |
| Autore | Marchini Antonio |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (366 p.) |
| Soggetto topico |
Medicine
Clinical & internal medicine |
| Soggetto non controllato |
oncolytic viruses
melanoma immunotherapy checkpoint inhibitors combinatory therapy reovirus oncolytic virus adenovirus oncolytic virotherapy targeting immunogenic cell death αvβ6 integrin oncolytic adenovirus cancer immunotherapy multi-stage immunostimulatory arming HSV-1 clinical trials newcastle disease virus NDV cancer immune checkpoint inhibitor PD-1 PD-L1 CTLA-4 type I interferon herpes simplex virus retargeted virus tropism retargeting tumor checkpoint inhibitor vaccination antigen-agnostic vaccination HER2 parvovirus tumor microenvironment combination therapy glioblastoma pancreatic cancer colorectal cancer measles virus vector engineering immune checkpoint blockade antitumor immune response delivery genetic modification biomarkers personalized oncolyticvirotherapy class I HLA immunosurveillance immunoediting oncogenic signaling RAS DNA methyltransferase inhibitor (DNMTi) viral mimicry epigenetic silencing adoptive T cell therapy CAR T cell pancreatic ductal adenocarcinoma vesicular stomatitis virus small molecule cancer immune therapy cancer therapy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566462203321 |
|
Marchini Antonio
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Outcomes and Therapeutic Management of Bladder Cancer
| Outcomes and Therapeutic Management of Bladder Cancer |
| Autore | Moschini Marco |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (120 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
bladder cancer
robotic-assisted open radical cystectomy survival propensity score age urothelial carcinoma outcome anesthesia recovery periods cognitive impairment gamma-cyclodextrins neuromuscular blockade robotic radical cystectomy glycogen clear-cell adenocarcinoma urinary bladder SEER program database female intracorporeal neobladder outcomes robotic sex-sparing methylation biomarkers FOXA1 GATA3 KRT20 molecular markers mRNA muscle-invasive bladder cancer PCR human epidermal growth factor receptor 2 indoleamine 2,3-dioxygenase programmed death ligand-1 immunotherapy nodal disease pN1 neoadjuvant adjuvant chemotherapy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557114503321 |
|
Moschini Marco
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
| Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| Autore | Pacak Karel |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (380 p.) |
| Soggetto non controllato |
polycythemia
peptide receptor radiotherapy vasculogenesis catecholamines neuroendocrine GTV adaptive immunity therapy resistance histology transgenic mice cryoablation spheroids energy metabolism somatostatinoma angiogenesis pheochromocytoma SDHD percutaneous ethanol injection metanephrines SDHB global longitudinal strain mutation normetanephrines catecholamine PASS PGL 177Lu-DOTATATE chromosomal alteration speckle-tracking echocardiography lL-6 dog percutaneous ablation stem-like tumor cells EPAS1 neural crest fluorescence imaging neutrophil xenograft inflammation head and neck weighted standard deviation FGF21 calorimetry HIF average real variability next-generation sequencing adrenocortical carcinoma carotid body hypoxia-inducible factor paraganglioma succinate dehydrogenase blood pressure variability arrhythmia mortality NF1 toll-like receptor GAPP NET subclinical systolic dysfunction pheochromocytoma and paraganglioma PET-CT pan-cancer analysis mouse pheochromocytoma cells innate immunity neurogenesis neuroendocrine tumor obesity hypotension hypoxia CNV detection 18F-FDOPA comparative genomics adrenomedullary function PCC pathogen-associated molecular patterns adrenal tumor radiotherapy 11C-hydroxy-ephedrine radiofrequency ablation PPGL minimally invasive procedure sporadic diabetes mellitus adrenal incidentaloma germline mutation immunotherapy VHL immunohistochemistry metastatic OR malignant pheochromocytoma erythropoietin postoperative targeted therapy PRRT metastatic mitochondria T cell TCA cycle meta-analysis pseudohypoxia ectopic secretion radiosensitization chromogranin A hereditary hypertension PET phosphorylation tyrosine hydroxylase |
| ISBN | 3-03921-655-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pheochromocytoma |
| Record Nr. | UNINA-9910367743903321 |
|
Pacak Karel
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polymeric Carriers for Biomedical and Nanomedicine Application
| Polymeric Carriers for Biomedical and Nanomedicine Application |
| Autore | Lima Sofia |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (186 p.) |
| Soggetto topico | Technology: general issues |
| Soggetto non controllato |
osteoarthritis
monosodium iodoacetate p47phox PLGA nanoparticles reactive oxygen species full factorial design optimization metronidazole nanocomposites sodium alginate chitosan PLGA hybrid polymers chitosan-PLGA polymer NMR DSC FT-IR covalent drug conjugation therapeutic nanodevice polymeric nanoparticles cancer therapy controlled drug delivery redox responsive PEG-block-PLA nanocarriers disulfide bond controlled release retinol nanosponge hydrogel Box-Behnken design pharmacokinetic terbinafine hydrogel niacinamide polyethene glycol (PEG) 400 solvent dermal delivery finite dose porcine skin dissolving microneedles multiple sclerosis PLP transdermal delivery tyrosol nanoparticles Design of Experiment (DoE) β cyclodextrin DNA binding glyconanoparticles immunotherapy infectious diseases mannose receptors nutraceuticals |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557739303321 |
|
Lima Sofia
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Precision Medicine in Solid Tumors
| Precision Medicine in Solid Tumors |
| Autore | Dey Nandini |
| Pubbl/distr/stampa | Basel, : MDPI Books, 2022 |
| Descrizione fisica | 1 electronic resource (304 p.) |
| Soggetto topico |
Medicine
Oncology |
| Soggetto non controllato |
pediatric tumors
tumor mutational burden TMB whole-exome sequencing gene panel sequencing immune checkpoint inhibitors glioblastoma prognosis overall survival extent of resection random forest Decision tree personalized precision oncology circulating free DNA liquid biopsy epidermal growth factor receptor tyrosine kinase inhibitor osimertinib comprehensive genomic profiling molecular genotyping intratumor heterogeneity multiple biopsies tumor evolution clonality classification strategic therapeutic intervention thymoma driver mutation sequencing molecular barcoding EGFR mutation EGFR-TKI cfDNA NGS digital enrichment next-generation sequencing solid cancer universal health-care system precision medicine presumed germline findings clinical guideline non-small cell lung cancer outcome adjuvant chemotherapy anaplastic lymphoma receptor tyrosine kinase HNSCC ctDNA tDNA DDR genes PARP inhibitors new drug development next-generation sequencing (NGS) open data regulatory reform tumor profiling test triple-negative breast cancer (TNBC) breast cancer targeted therapy TNBC subtypes immunotherapy cancer screening smoking electronic records PD-L1 cancer-associated fibroblasts resistance chemotherapy CTC immunocytochemistry parallel double-detection laboratory-friendly |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910595078103321 |
|
Dey Nandini
|
||
| Basel, : MDPI Books, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
